Paul Saladino· MD
it was revealed that eight of the 12 on that panel as well had Financial ties to manufacturers of cholesterol lowering drugs
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it was revealed that eight of the 12 on that panel as well had Financial ties to manufacturers of cholesterol lowering drugs
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it was later found that eight of the nine people on the nset the national the national cholesterol education panel had Financial ties to makers of statins
skepticism was inevitable once it was revealed that eight of the 12 on that panel as well had Financial ties to manufacturers of cholesterol lowering drugs
if you look at the the 2003-2004 AHA guidelines right to change the levels of LDL I think it was 8 out of 10 people had ties to the Statin industry